OptimizeRx stockholders elect five directors, approve say-on-pay at 2025 annual meeting

OptimizeRx Corp

All five director nominees elected; Catherine Klema received most votes (11,050,447 for).
Advisory say-on-pay approved with 5,443,720 in favor vs 3,857,653 against and 3,757,636 abstentions.
Ratification of UHY LLP as auditor approved with 15,162,244 votes for.
Total shares outstanding 18,493,447; broker non-votes of 2,874,955 on director and say-on-pay proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.